How Do Antibody-Drug Conjugates (ADCs) Fit into Precision Medicine for Gastric Cancer?
Antibody-drug conjugates or “ADCs” are a novel class of highly potent biopharmaceutical drug composed of an antibody linked, via a chemical linker, to a biologically active drug or cytotoxic compound. Nearly 150 investigational ADCs are currently in pre-clinical and clinical trials. Join Drs.
Category
  • Oncology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
What’s the Best Approach to Select Targeted Treatments for HER2+ Gastric Cancer and What are Practical Considerations?
Clinicians must be aware and up-to-date on the most effective approaches to management in order to provide patients with the most appropriate course of therapy. Join Drs.
Category
  • Oncology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
The Potassium Problem in Hemodialysis: Interprofessional Approaches to Hyperkalemia Management in ESRD
This Grand Rounds series is targeted to physician specialists in nephrology, cardiology, emergency medicine, and primary care, as well as pharmacists, nurses, nurse practitioners, and physician assistants who manage patients with ESRD.
Category
Format
  • Online live
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
  • Participation
Event date April 23, 2021
On Demand: Expert Exchange 2021: A Practical Guide to Navigating Novelty in Bladder Cancer: Equipping Clinicians in an Era of Rapid Change
CEC Oncology has incorporated our “Expert Exchange” format for educational activities most recently in our 2020 bladder cancer activities.
Category
  • Oncology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Event date April 15, 2021
2020 and Beyond: How Immunotherapy is Changing the Game in Bladder Cancer Management
It is estimated that there are >81,000 new cases of metastatic urothelial bladder cancer (mUBC) in the U.S each year, resulting in more than 17,000 bladder cancer specific deaths.
Category
  • Oncology
Format
  • Webinar recorded
Credits
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Focusing on the Role of the Advanced Bladder Cancer Care Team: Case Studies on Managing irAEs
Join Drs. Neal Shore, Gautam Jayram, and Nurse Tanya O’Neal as they discuss clinical considerations for managing immune-related adverse events that may occur at any time during therapy and, as of yet, there is no reliable means to predict who will develop them.
Category
  • Oncology
Format
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
IO Therapies in the Advanced Bladder Cancer Clinic: Aligning Your Team for Success
As the treatment paradigm for bladder cancer continuously evolves, all members of the oncology healthcare team must be equipped to evolve with it to ensure optimal patient care. With this evolution comes many questions for the bladder cancer treatment team. Join Drs.
Category
  • Oncology
Format
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Future Directions in Bladder Cancer Treatment: The Experts Weigh In
Immunotherapies are revolutionizing many cancer treatment regimens and show promise in locally advanced or metastatic bladder cancer. Immune checkpoint inhibitors are attempting to fill an unmet need in relapsed disease and biomarkers may assist in identifying patients most likely to respond.
Category
  • Oncology
Format
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Optimizing Heart Failure Outcomes by Addressing Iron Deficiency: Managed Care Implications and Considerations in the Emerging Era of Intravenous Iron
This adaptive educational activity is targeted to managed care professionals, physicians, and specialty pharmacists attending the 2021 Academy of Managed Care Pharmacy (AMCP) Annual Meeting.
Category
  • Cardiology
Format
  • Webinar live
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
Event date April 16, 2021
On Demand: Optimizing Heart Failure Outcomes by Addressing Iron Deficiency: Managed Care Implications and Considerations in the Emerging Era of Intravenous Iron
This adaptive educational activity is targeted to managed care professionals, physicians, and specialty pharmacists attending the 2021 Academy of Managed Care Pharmacy (AMCP) Annual Meeting.
Category
  • Cardiology
Format
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™

Pages